Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, amycretin
Novo Nordisk next-gen shot shows 22% weight loss in early results
Novo Nordisk on Friday announced early-stage trial results for its amycretin obesity drug for subcutaneous injection, saying people with obesity or overweight treated with the drug achieved a 22% weight loss after 36 weeks.
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
Novo Nordisk A/S (NYSE:NVO) released topline results from a phase 1b/2a trial with amycretin intended for once-weekly subcutaneous administration. The trial investigated the safety, tolerability, pharmacokinetics,
STAT
11h
Novo Nordisk’s next-generation obesity treatment shows promise in early study
A new weight loss drug from Novo Nordisk helped patients lose a large amount of weight, providing a boost for Novo in the ...
9h
on MSN
Novo Nordisk stock pops on phase I data for new weight-loss drug amycretin
Amycretin could give Novo a buzzy product in a newly competitive obesity market. It works similarly to existing GLP-1 ...
ncbiotech.org
2d
IMMvention Therapeutix to collaborate with Novo Nordisk on oral therapies for sickle cell, other chronic diseases
IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
Manson won't face charges
27 horses found dead
Barred from entering DC
Extradition challenge denied
Trump ends security detail
Cancels scientific meetings
Protections revoked
Woman indicted in car crash
Giant iceberg on the move
Bans some tattoos, clothes
‘Lassie' actor dies at 91
World's most polluted cities
Alleged assault cover-up suit
Wins Horse of the Year
Millions missed school
Fined over smartwatch burns
China's trade status bill
Retires from semifinal
$2.5B wildfire relief package
Crack down on fake reviews
Newark mayor criticizes raid
Unveils Operator agent
Suspends all trips to Yemen
Consumer sentiment falls
Proposes ending FEMA
NBA All-Star Game starters
Debuts AI assistant
Ex-Nebraska RB Jones dies
Hamas to release 4 hostages
US home sales fell
Reviews charter schools
Feedback